Pharmacokinetics of tacrolimus during the early phase after heart transplantation.
Molinaro
M
M
Department of Pharmacology, Pavia, Italy.
Regazzi
M B
MB
Pasquino
S
S
Rinaldi
M
M
Iacona
I
I
Campana
C
C
Viganò
M
M
D000328:Adult; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D001835:Body Weight; D004359:Drug Therapy, Combination; D005260:Female; D016027:Heart Transplantation / Q000276:immunology / Q000502:physiology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000097:blood / Q000493:pharmacokinetics* / Q000627:therapeutic use; D007677:Kidney Function Tests; D008111:Liver Function Tests; D008297:Male; D008875:Middle Aged; D011184:Postoperative Period; D012044:Regression Analysis; D016559:Tacrolimus / Q000097:blood / Q000493:pharmacokinetics* / Q000627:therapeutic use; D013997:Time Factors
D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents; D001379:Azathioprine; D016559:Tacrolimus